Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Better Therapeutics, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20
   10-K10-K
Revenues  0.00.0
            Revenue growth  -100.0% 
Cost of goods sold  0.00.0
Gross profit  0.00.0
            Gross margin   100.0%
Selling, general and administrative   [+]11.12.7
Research and development  19.43.7
EBITDA   [+]-28.9-6.2
            EBITDA margin   -78100.0%
Depreciation and amortization  1.60.1
EBIT   [+]-30.6-6.3
            EBIT margin   -79037.5%
Interest expense  0.20.1
Other income (expense), net  -9.70.2
Pre-tax income  -40.5-6.2
Income taxes  -0.20.2
            Tax rate  0.4% 
Net income  -40.3-7.9
            Net margin   -98675.0%
   
Basic EPS   [+]($3.11)($0.79)
Diluted EPS   [+]($3.11)($0.79)
   
Shares outstanding (basic)   [+]13.09.9
Shares outstanding (diluted)   [+]13.09.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy